For people with Type 1 diabetes, developing hypoglycemia, or low blood sugar, is an ever-present threat. When glucose levels become extremely low, it creates a life-threatening situation for which the standard treatment of care is injecting a hormone called glucagon.
MIT develops implantable device to automatically release emergency glucagon
- Post author:admin
- Post published:July 9, 2025
- Post category:uncategorized